Clinical Management of Anhedonia and Communication with Patients
Dr Andrew Cutler and Dr Greg Mattingly review current understanding of anhedonia. They discuss how clinicians can better evaluate it by effectively and candidly communicating with patients about anhedonia.
Improvement in Quality of Life and Function in Patients with Major Depressive Disorder
The expert psychiatrists discuss when to evaluate treatment efficacy and the impact of patients’ quality of life and function in such evaluations.
Candidate Patients for Dextromethorphan-bupropion
Dr Andrew Cutler and Dr Greg Mattingly talk about patient profiles they consider for treatment with dextromethorphan-bupropion.
Clinical Experience with Dextromethorphan-bupropion
The expert psychiatrists share their clinical experience with dextromethorphan-bupropion.
Clinical Data with Dextromethorphan-bupropion
Dr Greg Mattingly reviews the results of GEMINI and ASCEND trials, which led to approval of dextromethorphan-bupropion.
Dextromethorphan-bupropion for Treatment of Major Depressive Disorder
Dr Greg Mattingly explains the mechanism of action of dextromethorphan-bupropion, a new agent to treat Major Depressive Disorder.
Glutamatergic Signaling and New Mechanisms of Action for Treatment of Depression
Dr Andrew Cutler and Dr Greg Mattingly discuss newer mechanisms of action to treat patients with Major Depressive Disorder, in particular those with glutamatergic agents.
Novel Agents for the Management of Pediatric and Adult ADHD
Drs Rakesh Jain, Greg Mattingly, David W. Goodman, Birgit H. Amann, and Theresa R. Cerulli, discuss emerging agents in the pipeline for the management of pediatric and adult ADHD.
Role of Viloxazine in Adult ADHD Treatment
David W. Goodman, MD, leads a discussion on the use of viloxazine for the treatment of adults with ADHD.
Managing Patients with ADHD on Viloxazine
Birgit H. Amann, MD, and Greg Mattingly, MD, share strategies for mitigating adverse events with viloxazine in ADHD and its effect on metabolism of drugs.
Using Viloxazine in Clinical Practice for the Management of ADHD
Key opinion leaders in the management of ADHD comment on where they anticipate using viloxazine and other nonstimulants in the ADHD treatment landscape.
Clinical Profile of Viloxazine in the Treatment of ADHD
Greg Mattingly, MD, and David W. Goodman, MD, discuss the recent approval of viloxazine in children and its clinical profile in the pediatric and adult populations in ADHD.
Medication Challenges and Risks for Adult ADHD Treatment
Birgit H. Amann, MD; Rakesh Jain, MD, MPH; Theresa R. Cerulli, MD; and David W. Goodman, MD, share unmet needs and risks in the treatment of adult ADHD.
Safety and Efficacy of Medications for ADHD Management
Dr David W. Goodman reviews the efficacy and tolerability of different classes of medications for the management of ADHD.
Role of Integrative Treatment in Adult ADHD
Rakesh Jain, MD, MPH, explores the role of an integrative treatment approach in regard to nonpharmacological treatment for the management of adult ADHD.
Treatment Selection for Adult ADHD
Rakesh Jain, MD, MPH, leads a discussion on factors that guide treatment selection for adult patients with ADHD.
Impact of Telehealth on the Management of Adult ADHD
Experts in ADHD discuss the benefits and challenges of telehealth on the diagnosis and management of adult ADHD.
Goals of ADHD Treatment
Birgit H. Amann, MD, and Greg Mattingly, MD, review patient and provider goals of treatment and provide insight on evaluating response to treatment for ADHD.
Role of Pediatric ADHD Guidelines in Diagnosis of ADHD
Greg Mattingly, MD; David W. Goodman, MD; Birgit H. Amann, MD; and Theresa R. Cerulli, MD, evaluate the role of pediatric ADHD guidelines and common misconceptions in the diagnosis and treatment of ADHD.
Approaching the Diagnosis of ADHD
Drs Birgit H. Amann, David W. Goodman, and Greg Mattingly discuss signs and symptoms that may prompt testing for adult ADHD and share their considerations for approaching diagnosis.
Unmet Needs in ADHD
Experts in the management of ADHD comment on unmet needs in disease management in the areas of diagnosis, treatment, and coverage of symptoms.
Clinical Burden of Adult ADHD
Birgit H. Amann, MD; Rakesh Jain, MD, MPH; David W. Goodman, MD; Greg Mattingly, MD; and Theresa R. Cerulli, MD, share insight on the impact of ADHD on quality of life in adult patients.
Diagnosis, Continuation, and Remission of ADHD in Adulthood
Drs David W. Goodman, Rakesh Jain, Greg Mattingly, and Theresa R. Cerulli, discuss continuation of ADHD from childhood as well as data on remission of ADHD in adulthood.
Overview of Attention-Deficit/Hyperactivity Disorders (ADHD)
David W. Goodman, MD; Greg Mattingly, MD; and Birgit H. Amann, MD, provide an overview of ADHD, including its pathophysiology as well as its prevalence in the pediatric and adult populations.
2 Commerce Drive Cranbury, NJ 08512